<ARTICLE>           5
<LEGEND>
                    The Schedule contains summary financial 
                    information extracted from the financial
                    statements for PruTech Research and
                    Development Partnership II and is qualified in its
                    entirety by reference  to such financial statements
</LEGEND>
<RESTATED>          
<CIK>               0000774560

<NAME>              PruTech Research and Development Partnership II
<MULTIPLIER>        1

<FISCAL-YEAR-END>               Dec-31-1997

<PERIOD-START>                  Jan-1-1997

<PERIOD-END>                    Sep-30-1997

<PERIOD-TYPE>                   9-Mos

<CASH>                          3,381,048

<SECURITIES>                    141,875

<RECEIVABLES>                   0

<ALLOWANCES>                    0

<INVENTORY>                     0

<CURRENT-ASSETS>                3,522,923

<PP&E>                          0

<DEPRECIATION>                  0

<TOTAL-ASSETS>                  3,522,923

<CURRENT-LIABILITIES>           348,094

<BONDS>                         0

<PREFERRED-MANDATORY>           0

<PREFERRED>                     0

<COMMON>                        0

<OTHER-SE>                      3,174,829

<TOTAL-LIABILITY-AND-EQUITY>    3,522,923

<SALES>                         0

<TOTAL-REVENUES>                0<F1>

<CGS>                           0

<TOTAL-COSTS>                   0

<OTHER-EXPENSES>                0<F1>

<LOSS-PROVISION>                0

<INTEREST-EXPENSE>              0

<INCOME-PRETAX>                 0<F1>

<INCOME-TAX>                    0

<INCOME-CONTINUING>             0

<DISCONTINUED>                  0

<EXTRAORDINARY>                 0

<CHANGES>                       0

<NET-INCOME>                    0<F1>

<EPS-PRIMARY>                   0

<EPS-DILUTED>                   0

<FN>
<F1>
Registrant adopted the liquidation basis of accounting
on December 31, 1996, and, accordingly, does not 
reflect operations subsequent to 1996. See Note A to
the financial statements for further details.
</FN>